Patents by Inventor Gillian Rosemary Bullock

Gillian Rosemary Bullock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADDITIONAL THERAPEUTIC USE
    Publication number: 20120010258
    Abstract: The invention relates to the use of an AT1 receptor antagonist or an AT2 receptor modulator, respectively, or a pharmaceutically acceptable salt thereof, for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 receptors in the sub-epithelial area or increase of AT2 receptors in the epithelia.
    Type: Application
    Filed: June 13, 2011
    Publication date: January 12, 2012
    Inventors: Gillian Rosemary Bullock, Marc De Gasparo, Sabina Maria Ganter
  • ADDITIONAL THERAPEUTIC USE
    Publication number: 20100120877
    Abstract: The invention relates to the use of an AT1 receptor antagonist or or an AT2 receptor modulator, respectively, or a pharmaceutically acceptable salt thereof, for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 receptors in the sub-epithelial area or increase of AT2 receptors in the epithelia.
    Type: Application
    Filed: September 25, 2008
    Publication date: May 13, 2010
    Inventors: Gillian Rosemary Bullock, Marc De Gasparo, Sabina Maria Ganter
  • Additional therapeutic use
    Publication number: 20020155986
    Abstract: The invention relates to the use of an AT1 receptor antagonist or or an AT2 receptor modulator, respectively, or a pharmaceutically acceptable salt thereof, for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 receptors in the sub-epithelial area or increase of AT2 receptors in the epithelia.
    Type: Application
    Filed: February 6, 2002
    Publication date: October 24, 2002
    Inventors: Gillian Rosemary Bullock, Marc De Gasparo, Sabina Maria Ganter
  • Additional therapeutic use
    Patent number: 6465502
    Abstract: The invention relates to the use of an AT1 receptor antagonist or or an AT2 receptor modulator, respectively, or a pharmaceutically acceptable salt thereof, for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 receptors in the sub-epithelial area or increase of AT2 receptors in the epithelia.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: October 15, 2002
    Assignee: Novartis AG
    Inventors: Gillian Rosemary Bullock, Marc De Gasparo, Sabina Maria Ganter
  • AT1 receptor antagonist for the stimulation of apoptosis
    Patent number: 6174910
    Abstract: The invention provides the use of an AT1 receptor antagonist, or a pharmaceutical salt thereof, for producing a pharmaceutical preparation for the stimulation of apoptosis and for the treatment of pathological symptoms which are substantially reduced, halted or prevented by apoptosis, and also corresponding pharmaceutical preparations.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: January 16, 2001
    Assignee: Novartis AG
    Inventors: Marc De Gasparo, Gillian Rosemary Bullock, Leoluca Criscione